BRAF and cutaneous melanoma: Our recent findings indicated a role of the Rho/MRTF pathway in migration, invasion, and metastasis of aggressive human cutaneous melanoma [20], as well as in the acquired resistance of BRAF mutant melanoma cells to BRAF inhibitors [35].